''NIH names Dr. Gary H. Gibbons director of the National Heart, Lung, and Blood Institute''
National Institutes of Health Director Francis S. Collins M.D., Ph.D., announced today the selection of Gary H. Gibbons, M.D., as the new director of the NIH's National Heart, Lung, and Blood Institute (NHLBI). Dr. Gibbons is the founder and current director of the Cardiovascular Research Institute, chairperson of the Department of Physiology, and professor of physiology and medicine at the Morehouse School of Medicine in Atlanta. He expects to start his new position in the summer of 2012.
Gibbons' institute at Morehouse is recognized for its discovery science related to cardiovascular health of minority populations. His laboratory is focused on discovering novel mediators of vascular disease. His program involves collaborative efforts to study the functional significance of genomic variation and changes in gene activities due to 'epigenetic' modifications of DNA that do not involve a change in the genetic code, as factors that enhance the susceptibility to cardiovascular disease.
"It is my sincere pleasure to welcome Dr. Gibbons to the NIH team," said Collins. His extraordinary scientific skills, tremendous energy and bold vision will be an asset to NHLBI and NIH." Susan B. Shurin, M.D., will continue as acting director of NHLBI until Gibbons joins, at which point she will resume her role as the institute's deputy director. "I want to extend my deep gratitude to Susan for her strong leadership in this role," added Collins.
Gibbons will oversee the third largest institute at the NIH, with an annual budget of more than $3 billion and a staff of 917 federal employees. Gibbons will also direct his own lab at the NIH, focusing on predictive health and genomic medicine in minority populations. The NHLBI provides global leadership for research, training, and education programs to promote the prevention and treatment of heart, lung, and blood diseases and enhance the health of all individuals so that they can live longer and more fulfilling lives.
"It's an honor to join the NIH and lead the Heart, Lung, and Blood Institute," said Gibbons. "The globally recognized research and training supported by the NHLBI continues to advance biomedical knowledge in fields related to heart, lung, and blood diseases. I look forward to working with the institute staff and with the many researchers supported by the Institute to foster multidisciplinary approaches to improve disease prevention, diagnosis, and treatment that will advance the health of all Americans."
Gibbons has served as a member of the National Heart, Lung, and Blood Advisory Council (NHLBAC) since 2009, a position he resigned after being selected to be director of the NHLBI. He was also a member of the NHLBI Board of Extramural Experts, a working group of the NHLBAC. Gibbons has received 15 NHLBI-supported grants since 1997.
Under his leadership of the Cardiovascular Research Institute at the Morehouse School of Medicine, Gibbons directed NIH-supported research in the fields of vascular biology, genomic medicine, and the pathogenesis of vascular diseases. During his tenure, the Cardiovascular Research Institute emerged as a center of excellence, leading the way in discoveries related to the cardiovascular health of minority populations. Gibbons has received several patents for innovations derived from his research in the fields of vascular biology and the pathogenesis of vascular diseases.
Gibbons, who is originally from Philadelphia, earned his undergraduate degree from Princeton University in Princeton, N.J., and graduated magna cum laude from Harvard Medical School in Boston. He completed his residency and cardiology fellowship at the Harvard-affiliated Brigham and Women's Hospital in Boston. Prior to joining the Morehouse School of Medicine in 1999, Dr. Gibbons was a member of the faculty at Stanford University, in Stanford, Calif., from 1990 until1996, and Harvard Medical School from 1996 until 1999.
Throughout his career, Gibbons has received numerous honors, including election to the Institute of Medicine of the National Academies of Sciences; selection as a Robert Wood Johnson Foundation Minority Faculty Development Fellowship awardee; selection as a Pew Biomedical Scholar by the Pew Charitable Trusts; and recognition as an Established Investigator of the American Heart Association (AHA).
Dr. Gibbons also serves on several editorial boards for journals in cardiovascular medicine, the Juvenile Diabetes Foundation, and the AHA.
* * *
Full Article- Date added:
- Apr 5, 2012
Related Resources
2010 Pew Scholar Identifies Mammalian Immune Regulators
Changchun Xiao, a 2010 Pew scholar and assistant professor at The Scripps Research Institute, was lead author in a paper in Nature Immunology focusing on tiny RNA molecules. His findings demonstrated that mice with too little of the tiny RNA molecules were immune deficient, while mice with too many of the molecules developed an auto-immune disorder. His Pew supported research could inform vaccine production and drug development for autoimmune diseases and immune deficient diseases.
More info2012 Pew Scholar Receives Grant to Study Cataracts in Infants
Salil Lachke, a 2012 Pew scholar and assistant professor in University of Delaware’s Department of Biological Sciences, has received a $60,000 grant from the Knights Templar Eye Foundation. As one of 19 researchers across the country to receive this award, he aims to identify biological pathways leading to genetic cataracts.More info
Science That Takes Risks: Biomedical Researchers Receive Pew Awards
The 2013 classes of Pew scholars and Latin American fellows are researching the basis of perplexing health problems—including diabetes, autism, Parkinson's disease, and cancer. More infoQuiz: Biomedical Science
Every day, researchers learn more about how our bodies work. Their discoveries point the way to new techniques to treat and prevent disease. Take our quiz to test your knowledge of biomedical science! More info
From Autism to Diabetes to Parkinson's Disease: Pew Funds 22 Early-Career Scientists to Take Calculated Risks
Twenty-two of the nation’s most enterprising researchers were named Pew Scholars in the Biomedical Sciences by The Pew Charitable Trusts for 2013. The scholarships provide flexible funding to early-career scientists researching the basis of perplexing health problems such as diabetes, autism, Parkinson’s disease, and cancer. Learn more about the scientists and their research.
More infoNational Cancer Research Month
May is National Cancer Research Month, and Pew’s biomedical scholars and Latin American fellows are doing their part to address the disease, which affects nearly 13 million people in the United States, according to the American Cancer Society. More infoSeven Pew Scholars Named HHMI Investigators
On May 9, the Howard Hughes Medical Institute (HHMI) announced that 27 of the nation’s top biomedical researchers—including seven Pew scholars—will become HHMI investigators and will receive the flexible support necessary to move their research in creative new directions. The Pew scholars named HHMI investigators are Peter Baumann (2003), Michael Dyer (2004), Nicole King (2004), Tirin Moore (2004), Dyche Mullins (2000), Michael Rape (2007), and Rachel Wilson (2005).
More info2009 Pew Biomedical Scholar Charles Mullighan Helps Identify Mutations Linked to Brain Tumors
2009 Pew Biomedical Scholar Charles Mullighan was part of a research team at St. Jude Children's Research Hospital which recently found mutations responsible for more than half of a subtype of childhood brain tumors. Their paper in Nature Genetics pinpointed alterations in two genes that increased the risk of low-grade gliomas—the most common childhood tumors of the brain and spinal cord—and identified an existing drug as a possible treatment.
More info2012 Pew Scholar Earns ARI Young Investigator Grant
Salil Lachke, a 2012 Pew scholar and assistant professor of biological sciences at the University of Delaware, has been selected by the Alcon Research Institute as a 2013 Young Investigator. As one of just eight researchers worldwide to receive the $50,000 grant, Dr. Lachke will continue his work on an online tool he created to discover genes related to glaucoma and other eye diseases.
More info2011 Pew Scholar awarded $1.13 million from NIH
Jeff Gore, a 2011 Pew Scholar and assistant professor of physics at MIT, has been awarded a four-year, $1,131,603 grant from the National Institute of General Medical Sciences – one of the 27 National Institutes of Health – to pursue research into cooperation and cheating in the evolution of antibiotic resistance in bacteria.
More info2009 Pew Scholar Shows Cells Can Naturally “Reprogram” Themselves
Ben Stanger, a 2009 Pew scholar and assistant professor at University of Pennsylvania’s Perelman School of Medicine, has demonstrated that cells can change their identities under normal conditions in the body. In a study published in Genes and Development, Dr. Stanger pinpointed the gene that allows the main type of liver cells in mammals to convert into the cells lining bile ducts.
More infoLearning How Genetic Seeds Are Sown
To understand how embryos develop, many researchers look to animal models such as worms and frogs. But Mary Gehring, a 2011 Pew Biomedical Scholar and assistant professor of biology at the Massachusetts Institute of Technology, turns to plants—even weeds.
More info1991 Pew Scholar Wins Prestigious Gairdner Award
One of the six recipients of the 2013 Canada Gairdner International Awards is Stephen Elledge, a 1991 Pew Scholar and Gregor Mendel Professor of Genetics and of Medicine at Harvard Medical School and Brigham and Women’s Hospital. With the $100,000 prize, Dr. Elledge will study the DNA damage response—a signaling pathway that allows cells to repair themselves when DNA is impaired. More infoWomen's History Month - Women in STEM
Learn more about the women scientists of Pew's Biomedical Scholar's Program and help celebrate Women's history month.
More info
